Pacira Pharmaceuticals, Inc. to Present at the UBS Global Life Sciences Conference
Presentation to be Webcast at 4:30 pm ET on Wednesday, September 19th
PARSIPPANY, N.J.--(BUSINESS WIRE)-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that David Stack, president and chief executive officer of Pacira Pharmaceuticals (PCRX), is scheduled to present at the UBS Global Life Sciences Conference at the Grand Hyatt New York on Wednesday, September 19 at 4:30 p.m. ET. Mr. Stack is expected to present an overview of the company.
A live audio webcast of the Pacira presentation can be accessed by visiting the Investors & Media section of the company's website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.
Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other approved products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time. Additional information about Pacira is available at http://www.pacira.com.
Pacira Pharmaceuticals, Inc.
James S. Scibetta, 973-254-3570
Chief Financial Officer
Source: Pacira Pharmaceuticals, Inc.Copyright Business Wire 2012